Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
Buyer
London School of Hygiene & Tropical Medicine
Value
£975,000
Published
21 Aug 2023
Closes
5 Jan 2022
Procurement details
Source
Find a Tender
Region
Camden and City of London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
33141310
Syringes
33141320
Medical needles
33621000
Medicinal products for the blood and blood-forming organs
33621200
Antihaemorrhagics
33698000
Clinical products
39299100
Glass ampoules
44617100
Cartons
Lots
Lot 1 Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
£975,000
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births. Three arms include experimental treatm...
Delivery: Camden and City of London
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.